P2.01-02 CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC

Category Primary study
JournalJournal of Thoracic Oncology
Year 2019
This article has no abstract
Epistemonikos ID: f8acfe6a8c80f24537bb28719ace674c7c8abb16
First added on: Feb 11, 2025